Back to Authors

Pan, Max

Mayo Clinic

AnHeart Therapeutics, NY, USA

Citations 1

TRUST-II: a global phase II study of taletrectinib in ROS1 -positive non-small-cell lung cancer and other solid tumors

Future Oncology | May 17, 2024 | Volume: 19 | Issue: 2 | Pages: 123-135

10.2217/fon-2022-1059 | PMID 36877099